A CCR2/CCR5-dual antagonist, BMS-A, offers a potential novel oral therapy for the treatment of autoimmune diseaseQihong Zhao,Jian Pang,Kim W Mcintyre,Kathleen Gilloolly,Robert Townsend,J Postelnek,R Robert Grafstrom,Bokang He,Gregory Ford,Stacey Conarello,Jenny Xie,Paul Davies,Joel C Barrish,James M Trzaskos,Luisa Saltercid,Murray Mckinnon,Sandhya Mandlekar,Percy H CarterJOURNAL OF IMMUNOLOGY(2009)引用 25|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要